Torno Capital, LLC Celldex Therapeutics, Inc. Transaction History
Torno Capital, LLC
- $624 Billion
- Q3 2024
A detailed history of Torno Capital, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Torno Capital, LLC holds 5,300 shares of CLDX stock, worth $149,142. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,300Holding current value
$149,142% of portfolio
0.03%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CLDX
# of Institutions
207Shares Held
67.3MCall Options Held
1.69MPut Options Held
980K-
Wellington Management Group LLP Boston, MA9.24MShares$260 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$132 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$109 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.46MShares$97.3 Million9.64% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$93.8 Million1.99% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.32B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...